Literature DB >> 3271606

Endothelium-derived relaxing factor released from cultured cells: differentiation from nitric oxide.

G J Dusting1, M A Read, A G Stewart.   

Abstract

1. Endothelium-derived relaxing factor (EDRF) is an extremely labile mediator thought to be identical to nitric oxide (NO). 2. A cascade superfusion technique was used to bioassay EDRF released from bovine aortic endothelial cells grown to confluence on microcarrier beads. 3. Bradykinin (1-100 nmol/l), infused through a 1 cm column of endothelial cells on microcarriers, released an EDRF-like substance that caused relaxations of de-endothelialized strips of rabbit aorta (precontracted with phenylephrine). These relaxations diminished on successive tissues in the cascade, when compared with those produced by glyceryl trinitrate as a stable standard. 4. Haemoglobin (1 mumol/l), infused directly over the bioassay tissues, abolished bradykinin-induced relaxations and these were restored within 5 min after removal of haemoglobin. The infusion did not affect the relaxations produced by glyceryl trinitrate in this system. 5. Methylene blue (20 mumol/l) inhibited bradykinin-induced relaxations when infused over the rabbit aortae, and reduced those relaxations produced by glyceryl trinitrate. The effects of bradykinin, but not glyceryl trinitrate, were partially restored after removing methylene blue. 6. These data are consistent with the known effects of these compounds on the activity of NO, and on EDRF in isolated blood vessels. 7. The activity of EDRF (released by bradykinin) was compared directly with NO on strips of guinea-pig trachea (de-epithelialized) interposed in cascade between two rabbit aortae; all strips were precontracted with histamine and phenylephrine. 8. A submaximal dose of NO that matched the relaxation produced by EDRF on the uppermost aorta, caused relaxation of the trachea, but EDRF had no effect on this tissue. In addition, the NO-induced relaxation of the lower aorta was greater than that produced by EDRF. 9. These data indicate that EDRF does not have identical biological activity to NO. EDRF could contain an NO moiety attached to a carrier molecule that is bound and stabilized in tracheal tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3271606     DOI: 10.1111/j.1440-1681.1988.tb01049.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

Review 1.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

2.  Inhibition of vascular smooth muscle relaxation by LY83583.

Authors:  E Malta; P S Macdonald; G J Dusting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

3.  Comparison of relaxation responses of vascular and non-vascular smooth muscle to endothelium-derived relaxing factor (EDRF), acidified sodium nitrite (NO) and sodium nitroprusside.

Authors:  T M Cocks; J A Angus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

4.  Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells.

Authors:  A G Stewart; P N Dubbin; T Harris; G J Dusting
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators.

Authors:  P J Henry; O H Drummer; J D Horowitz
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

6.  Bioassay of nitric oxide released upon stimulation of non-adrenergic non-cholinergic nerves in the canine ileocolonic junction.

Authors:  G E Boeckxstaens; P A Pelckmans; I F Ruytjens; H Bult; J G De Man; A G Herman; Y M Van Maercke
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

7.  Evidence for an intracellular action of platelet-activating factor in bovine cultured aortic endothelial cells.

Authors:  A G Stewart; P N Dubbin; T Harris; G J Dusting
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

8.  Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways.

Authors:  B Gaston; J Reilly; J M Drazen; J Fackler; P Ramdev; D Arnelle; M E Mullins; D J Sugarbaker; C Chee; D J Singel; Joseph Loscalzo; Jonathan Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.